Immunoassay Reagent Elecsys® CA 125 II CLIA Non-Waived 300 Tests

Features

• Immunoassay for the in vitro quantitative determination of OC 125 reactive determinants in human serum, Li‑heparin, K2‑EDTA and K3‑EDTA, as well as Li‑heparin plasma tubes containing separating gel on cobas e analyzers
• These determinants are associated with a high molecular weight glycoprotein in serum and plasma of women with primary epithelial invasive ovarian cancer (excluding those with cancer of low malignant potential
• This immunoassay is indicated for use as an aid in the detection of residual or recurrent ovarian carcinoma
• This immunoassay is further indicated for use in monitoring patients for disease progress or response to therapy